Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
This section provides an analysis of the Global Fund grant portfolio, comprising more than 1,000 programs across more than 140 countries. Data is provided by country, by disease component, or by grant.
Individual country pages also provide detailed information on each grant, including amounts received, results obtained, and grant performance, as well as key contacts and relevant reports.
Criteria for national results reporting
In some countries, due to challenges and limitations inherent in the health information systems, some indicators may be able to report only at the national level, as it is not possible to disaggregate and report on Global Fund-specific results, or when doing so would lead to the creation of parallel reporting systems. Results of Global Fund-supported programs may include services and commodity deliverables co-financed by others, including domestic counterpart financing and other donor support.
In cases where only national targets, or where both grant-specific and national targets are defined and reported by countries to the Global Fund for program monitoring purposes, the Global Fund has developed criteria to assess whether to incorporate national data as results of Global Fund-supported programs. Criteria exist for determining reporting on the important indicators (people currently receiving ART, PMTCT, TB case detection and the distribution of bed nets).
These criteria were presented and reviewed with international partner agencies – PEPFAR/WHO/UNAIDS for people receiving ART, PMTCT; WHO for TB case detection and distribution of bed nets. Where national results are reported by the grants on the above indicators, and where such results are significant , the following criteria are used to determine whether these can be incorporated in aggregate reporting:
 For people receiving ART, figures reported to the Global Fund as national and >100,000. For TB case detection, figures reported to the Global Fund as national in the 22 TB high burden countries. For the distribution of nets, figures reported to the Global Fund as national in the 31 malaria endemic countries.
 Data sources: For HIV, AIDS expenditure data based on National AIDS Spending Assessment methodology UNGASS Indicator 1, from UNAIDS Report on the Global AIDS Epidemic 2013. For TB, expenditure data (received amounts) from Global Tuberculosis Report 2013. For malaria, WHO World Malaria Report 2013 (forthcoming)
 E.g. for HIV: drug provision, HR, infrastructure, laboratory/testing.
All amounts are in USD or the USD-equivalent for grants signed in EUR
The geographical designations employed by the Global Fund do not represent or imply any opinion or judgment on the legal status of any country, territory, city or area on its governmental or state authorities, or on the delimitation of its frontiers or boundaries.